Leptomeningeal Carcinomatosis

What is Leptomeningeal Carcinomatosis?

Overview

Leptomeningeal carcinomatosis (also called carcinomatous meningitis or, rarely, gliomatosis cerebri) occurs when cancer cells spread into the cerebrospinal fluid (CSF) that surrounds the brain and spinal cord. This typically happens when cancers that started elsewhere in the body metastasize to the central nervous system at a later stage of disease—often after solid brain metastases have developed.

Cancers most often associated with leptomeningeal spread include breast cancer, lung cancer, melanoma, lymphoma, and certain gastrointestinal cancers.

Because the cancer cells travel within the CSF, they can affect many areas of the brain, spinal cord, and nerve roots at the same time. Symptoms may include seizures, altered mental status, weakness or numbness in the arms or legs, pain, and problems with balance or coordination.

Diagnosis is usually made through a lumbar puncture (spinal tap) that detects cancer cells in the CSF. Some patients develop hydrocephalus (a build-up of CSF in the brain), which can cause headaches, confusion, and gait problems. A ventriculoperitoneal (VP) shunt can relieve this pressure and also allow direct administration of chemotherapy into the CSF. If hydrocephalus is not present, an Ommaya reservoir may be implanted to deliver chemotherapy directly into the fluid spaces.

Who is Affected?

Leptomeningeal carcinomatosis can occur in people of any age who have advanced cancer, but it is more common in:

• Adults with aggressive or late-stage cancers, especially breast, lung, and melanoma.
• People with cancers that have already spread to the brain or spine.
• Patients with certain blood cancers (e.g., lymphoma, leukemia).

It is estimated to occur in 5–8% of patients with metastatic cancer, though the rate is higher in certain cancer types.

Leptomeningeal Carcinomatosis Symptoms & Causes

Symptoms

Symptoms depend on where in the nervous system the cancer cells are affecting CSF flow and nerve structures. They may develop gradually or progress quickly.

Common symptoms include:

• Persistent headaches
• Seizures
• Confusion or memory loss
• Weakness or numbness in arms or legs
• Loss of coordination or balance
• Facial weakness or double vision
• Pain in the neck, back, or limbs
• Difficulty swallowing or speaking

In severe cases, patients may experience rapidly worsening neurological function.

Causes

Leptomeningeal carcinomatosis occurs when cancer cells enter the CSF via:

• Direct spread from nearby brain or spine metastases.
• Microscopic spread through blood vessels into the meninges.
• Surgical manipulation or tumor rupture (less common).

The cancer cells then circulate in the CSF and can seed multiple areas, making treatment more challenging.

When to See a Doctor

Seek immediate medical attention if you have a history of cancer and experience:

• New or worsening neurological symptoms.
• Severe headaches or confusion.
• Unexplained seizures.
• Weakness, numbness, or vision changes.

Early recognition is key to starting treatment quickly, which can help control symptoms and maintain quality of life.

Leptomeningeal Carcinomatosis Diagnosis

Diagnosing leptomeningeal carcinomatosis requires a combination of:

Because cancer cells may not always be present in the first sample, multiple lumbar punctures may be needed for confirmation.

Leptomeningeal Carcinomatosis Treatment & Outcomes

Treatment Options

Treatment focuses on controlling symptoms, slowing disease progression, and improving or preserving neurological function. Options may include:

• Intrathecal chemotherapy: Chemotherapy delivered directly into the CSF via a VP shunt or Ommaya reservoir (e.g., methotrexate, cytarabine).
• Systemic chemotherapy: Depending on the type of primary cancer and its responsiveness.
• Targeted therapy or immunotherapy: For cancers with specific genetic mutations.
• Radiation therapy: To treat localized symptomatic areas or to help restore CSF flow.
• Ventriculoperitoneal shunt: To relieve hydrocephalus and associated symptoms.

Supportive care, including seizure control, pain management, and physical therapy, is also an important part of treatment.

Patient Outcomes

The outlook for leptomeningeal carcinomatosis depends on the primary cancer type, how well it responds to therapy, and the patient’s overall health. While this condition is serious, prompt treatment can improve symptom control, extend survival, and help maintain independence for as long as possible. Advances in targeted therapies are offering new hope for select patients.

Managing Leptomeningeal Carcinomatosis

Patients living with leptomeningeal disease benefit from:

• Close follow-up with oncology and neurosurgery teams.
• Regular imaging and CSF monitoring to track treatment response.
• Physical, occupational, and speech therapy as needed.
• Emotional and psychological support for both patients and families.
• Attention to nutrition, rest, and overall wellness to maintain strength during treatment.

Meet our Expert Specialists & Surgeons

Garni Barkhoudarian, MD

Neurosurgery

Experience Compassionate, Expert Care

At Pacific Neuroscience Institute, our multidisciplinary team has extensive experience diagnosing and treating leptomeningeal carcinomatosis. We offer advanced imaging, minimally invasive neurosurgical techniques, and direct intrathecal chemotherapy delivery systems to optimize outcomes.

We collaborate closely with oncologists, radiation specialists, and palliative care providers to ensure that every patient receives a personalized treatment plan with a focus on quality of life.

Learn More About Leptomeningeal Carcinomatosis

Resources